Evidence map›Paper›PMID 26820844›Full record

ArticleClinical and experimental nephrology2017

Report of novel genetic variation in NPHS2 gene associated with idiopathic nephrotic syndrome in South Indian children.

Mohanapriya Chinambedu Dhandapani, Vettriselvi Venkatesan, Nammalwar Bollam Rengaswamy, Kalpana Gowrishankar, Sudha Ekambaram, Prabha Sengutavan, Venkatachalam Perumal

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Clinical and experimental nephrology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. BioMed research international · 2017
    Review
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Mohanapriya Chinambedu DhandapaniV Clin Bio Labs, Central Research Facility, Sri Ramachandra University, Porur, Chennai, 600 116, India.
Vettriselvi VenkatesanDepartment of Human Genetics, Sri Ramachandra University, Porur, Chennai, 600 116, India.
Nammalwar Bollam RengaswamyDepartment of Pediatric Nephrology, Mehta Children's Hospital, Chennai, 600 031, India.
Kalpana GowrishankarDepartment of Medical Genetics, Kanchi Kamakoti CHILDS Trust Hospital, Chennai, 600 034, India.
Sudha EkambaramDepartment of Pediatric Nephrology, Mehta Children's Hospital, Chennai, 600 031, India.
Prabha SengutavanDepartment of Nephrology, Sri Ramachandra University, Porur, Chennai, 600 116, India.
Venkatachalam PerumalDepartment of Human Genetics, Sri Ramachandra University, Porur, Chennai, 600 116, India. venkip@yahoo.com.
Sri Ramachandra Institute of Higher Education and Research · INDr. Mehta's Children's Hospital · INKanchi Kamakoti CHILDS Trust Hospital · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSteroid-resistant nephrotic syndrome (SRNS) is found in 10-20 % of children with idiopathic nephrotic syndrome (INS). In SRNS patients, common histopathological subtypes are Focal segmental glomerulosclerosis (FSGS) (53 %) and minimal change disease (MCD) (27 %). Familial forms of FSGS constitute podocyte diseases with varying severity and age of onset. Podocin gene (NPHS2) mutations cause childhood-onset steroid-resistant FSGS and MCD to adult-onset FSGS. In view of genetic variations and susceptibility to the disease, the present investigation was undertaken to study the pattern of genetic mutation in children from South India.

methodsMutation analysis was carried out by direct sequencing of the entire NPHS2 gene (eight exons) using specific primers in 200 INS (100 SRNS and 100 steroid sensitive) children and 100 healthy controls. The allele and genotype frequencies of NPHS2 gene were calculated for both cases and controls as per Hardy-Weinberg equilibrium.

resultsAmong the SRNS patients, 18 % revealed both heterozygous and homozygous mutations. Out of 12 mutations, 8 were homozygous and 4 were heterozygous. Interestingly, we found two novel SNPs in exon 4 of NPHS2 gene, which are documented and submitted to dbsnp database (Ref rs12401711 and rs12401708).

conclusionMutational analysis of NPHS2 would be advisable at the start of treatment. The genetic variations detected in the study would serve as the important molecular marker in treating the children's at early stage, which also enables to detect carriers, prenatal diagnosis and provide genetic counseling to couples at risk.

Indexed as

MutationPolymorphism, Single NucleotideAdolescentAge of OnsetCase-Control StudiesChildChild, PreschoolDNA Mutational AnalysisExonsFemaleGene FrequencyGenetic Association StudiesGenetic Predisposition to DiseaseGenetic TestingHeterozygoteHomozygoteIntracellular Signaling Peptides and ProteinsMembrane ProteinsNPHS2 proteinNPHS2 mutationsPolymorphismSteroid-resistant nephrotic syndrome

Identifiers

PMID26820844
OpenAlexW4246486160

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.